ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646859 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646859; 2) Community: the network communities that were significantly associated with the response to NSC 646859; 3) Molecule: the relationships between components within communities and NSC 646859; 4) MDR: the compounds that were significantly associated with the NSC 646859.

NSC Compound Enrichment Correlation
NSC 695046 Null 0.0252510646170347 0.19151095
NSC 696652 Null 0.0252510646170347 0.087702989
NSC 718157 Null 0.0252510646170347 -0.066047543
NSC 731703 (O2-[2,4-dinitro-5-(N-methyl-N-4-carboxyphenylamino)phenyl 1-N,N-Dimethylamino)diazen-1-ium-1,2-diolate 0.0252510646170347 -0.017112904
NSC 748264 Null 0.0252510646170347 -0.10878356
NSC 753938 2,7-bis(3-(dimethylamino)propyl)-4,10-bis(3-(dimethylamino)propylamino)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone 0.0252510646170347 0.098986194
NSC 686559 Null 0.0273093708703111 0.033530514
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0273093708703115 -0.03420094
NSC 603831 Acteoside 0.0273093708703115 -0.22033967
NSC 612789 Acrovestone 0.0273093708703115 0.22013948
Total:26  Current:11    [First] [Prev] [Next] [Last]